Violations of exhibiting and FDA rules at an American Psychiatric Association Annual Meeting

Peter Lurie, Tung Tran, Sidney Manuel Wolfe, Robert Goodman

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


We conducted a cross-sectional study of all exhibit booths for the 24 pharmaceutical companies at the 2.002. American Psychiatric Association (APA) convention. We collected and categorized one of each item distributed by the companies at each booth. A total of 2.68 items were collected from 2.4 companies (median = 8). The most common categories of items were "reprints or pamphlets" (37%) and "non-educational gifts" (27%), including music CDs and invitations to dinners and museums. There were a total of 16 violations of the APA's own exhibit rules: eight companies had one violation and two companies had four violations. Four companies engaged in FDA-prohibited off-label promotion; one also violated the APA code. Over half of all companies (54%) were in violation of either APA rules or FDA regulations. The APA's voluntary code has failed to adequately reduce inappropriate promotional activity at the annual APA meeting.

Original languageEnglish (US)
Pages (from-to)389-399
Number of pages11
JournalJournal of public health policy
Issue number4
StatePublished - 2005


  • Advertising
  • Drug labeling
  • Marketing
  • Medical meetings
  • Pharmaceutical industry
  • Psychiatry

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Violations of exhibiting and FDA rules at an American Psychiatric Association Annual Meeting'. Together they form a unique fingerprint.

Cite this